Zdrowie i gospodarka · 25/09/2025
FDA Announces Draft Guidance for Expedited Regenerative Medicine Therapies
The FDA is releasing a draft document outlining expedited development and review recommendations for regenerative medicine therapies for serious conditions, which will eventually replace the 2019 guidance.